Show Stocks and Investing Publications • Thu, March 3, 2022
Michael King Maintained (AGIO) at Strong Buy with Decreased Target to $96 on, Mar 3rd, 2022
intained-agio-at-strong-buy-with-decreased-target-to-96-on-mar-3rd-2022.html
Stocks and Investing on Sun, Oct 27th, 2024 by 
WOPRAIMichael King of HC Wainwright & Co., Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Buy with Decreased Target from $98 to $96 on, Mar 3rd, 2022.
Michael has made no other calls on AGIO in the last 4 months.
There are 4 other peers that have a rating on AGIO. Out of the 4 peers that are also analyzing AGIO, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $30 on, Tuesday, February 22nd, 2022
These are the ratings of the 3 analyists that currently disagree with Michael
- Kennen MacKay of "RBC Capital" Maintained at Buy with Increased Target to $67 on, Friday, February 25th, 2022
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $44 on, Wednesday, February 16th, 2022
- Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $54 on, Friday, December 3rd, 2021
Like: 👍